Tokyo, Japan

Kiyotaka Obata

This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyotaka Obata. Retrieved from https://idiyas.com/inventor/kiyotaka-obata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Overview of Inventor Kiyotaka Obata

Introduction: Kiyotaka Obata is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative developments in antifungal agents. His work reflects the intersection of creativity and science, showcasing the potential of inventions to improve health outcomes.

Latest Patents: Kiyotaka Obata holds a patent for an antifungal agent, which represents a notable advance in the fight against fungal infections. This invention highlights his dedication to medical innovation and addresses critical health challenges.

Career Highlights: Currently, Kiyotaka is employed at Taisho Pharmaceutical Co., Ltd., a renowned company in the pharmaceutical industry. His role at Taisho allows him to leverage his expertise in developing effective health solutions. With one patent to his name, his career reflects a commitment to advancing pharmaceutical research and innovation.

Collaborations: Throughout his career, Kiyotaka Obata has collaborated with talented colleagues, including Toshi Akashi and Shigeo Tanaka. These partnerships have enhanced his research and contributed to the successful development of his innovative solutions in the pharmaceutical arena.

Conclusion: Kiyotaka Obata's contributions as an inventor underline the importance of innovation in health care. With his antifungal agent patent and collaborative spirit, he continues to make strides in the pharmaceutical industry, exemplifying the impact that dedicated inventors can have on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…